Search - tctmd.com

Displaying 41 - 60 of 136

Sort: Relevancy | Date

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Conference News AHA 2023

Simultaneous Dual Cardioversion of AF Lessens Failure Rates in Obese Patients

Todd Neale

November 14, 2023

News Conference News AHA 2023

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Yael L. Maxwell

November 14, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Shelley Wood

September 28, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Caitlin E. Cox

August 01, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

Advertisement

Who Benefits Most From Semaglutide and How Long Will That Take?

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Simultaneous Dual Cardioversion of AF Lessens Failure Rates in Obese Patients

New CVD Risk Tool Can Spur Even Earlier Talk About Prevention

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

FDA Grants Tirzepatide a New Indication for Obesity Management

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content